Dashboard
● AI Ready

Good morning, Doctor.

Your AI-powered prior authorization command center.

PA Success Rate
87%
↑ 12% from last month
Avg. Approval Time
3.2 days
↓ 1.4 days improved
Active PAs
24
8 need attention
Pending Appeals
6
3 urgent
Quick Actions
Most common workflows
AI Capabilities
Powered by Claude AI
PA
Auto-generate PA letters
Complete, insurer-specific letters in seconds
Predict
Predict approval criteria
Anticipate what each insurer needs before denial
Appeal
Intelligent denial appeals
Targeted appeals citing guidelines & case law
P2P
Peer-to-peer call scripts
Exact words to say, objection handling ready
Rheumatology Drug Coverage Landscape
Common PA requirements by drug class
Drug Class Key Examples Typical Step Therapy PA Complexity Action
TNF Inhibitors Humira, Enbrel, Remicade, Cimzia, Simponi 2+ csDMARDs (MTX required for RA) Moderate
JAK Inhibitors Xeljanz, Olumiant, Rinvoq MTX + 1 TNFi (most payers) High
IL-6 Inhibitors Actemra, Kevzara MTX ± TNFi failure Moderate
IL-17 Inhibitors Cosentyx, Taltz, Bimzelx NSAIDs ± csDMARDs (AS/PsA) Moderate
B-Cell Agents Rituxan, Benlysta, Saphnelo MTX + 2 TNFi (rituximab RA) High

PA Submission Tool

AI-powered prior authorization preparation and letter generation

1
Select Drug
2
Patient & Insurance
3
Clinical Data
4
Generate Letter
Search & Select Drug
Choose the medication requiring prior authorization
Patient Information
Insurance Information
Clinical Documentation
The stronger the clinical data, the better the PA outcome
Include: drug name, dose, duration, outcome, reason for stopping — the more specific the better
AI Letter Generation
Generate a comprehensive, insurer-specific PA letter

Insurance Requirements Database

PA requirements, contact info, and step therapy policies by insurer

Step Therapy Requirements Matrix
By drug class and major insurers
Drug / Class UHC BCBS Aetna Cigna Medicare
TNF Inhibitors
Humira, Enbrel, etc.
2 csDMARDs + biosimilar 2 csDMARDs CPB 0174 criteria 2 csDMARDs Medical necessity
JAK Inhibitors
Xeljanz, Rinvoq, Olumiant
MTX + 1 TNFi required MTX + 1 TNFi MTX + 1 TNFi MTX + 1 TNFi Plan dependent (Part D)
IL-6 Inhibitors
Actemra, Kevzara
MTX + 1 TNFi (RA) MTX ± TNFi CPB 0473 criteria MTX + TNFi Medical necessity
IL-17 Inhibitors
Cosentyx, Taltz
NSAIDs/csDMARDs (PsA/AS) NSAIDs + csDMARDs NSAIDs + csDMARDs NSAIDs + csDMARDs Medical necessity
Rituximab (RA)
Rituxan + biosimilars
MTX + 2 TNFi + Hep B MTX + 1-2 biologics MTX + 2 TNFi MTX + 1 TNFi LCD criteria + Hep B

Denial Appeal Generator

AI-powered denial analysis and appeal letter generation

Denial Details
Appeal Process Timeline
1
Receive Denial
Note date — appeal deadlines start here (typically 30-180 days)
2
Request P2P (within 14-30 days)
Peer-to-peer is often fastest path — try before formal appeal
3
Submit Level 1 Internal Appeal
Formal written appeal with clinical evidence
4
External Independent Review (IRO)
Request external review if internal appeal denied
5
State Insurance Commissioner
Escalate to state regulator for commercial plan denials

Peer-to-Peer Preparation

AI-generated call scripts, objection handling, and winning arguments

Case Setup
Tell us what you're dealing with
Before the Call — Checklist
Your P2P Script Will Appear Here
Fill in the case details on the left and click Generate to get your personalized peer-to-peer call script with opening lines, arguments, objection handling, and closing strategy.

Settings

Configure your RheumAuth instance

Anthropic API Key
Required for all AI features
Your API key is stored only in your browser's local storage. It is never sent anywhere except directly to Anthropic's API.
Get API Key →
Practice Information
Used in generated letters
About RheumAuth
RheumAuth is a clinical decision support tool for rheumatology practices. It helps prepare prior authorization requests, appeal denials, and prepare for peer-to-peer reviews using AI.

Disclaimer: RheumAuth is a support tool. All generated content should be reviewed by a licensed physician before submission. Insurance requirements change frequently — always verify with the payer directly.

PA Tracker

Track every prior authorization — status, deadlines, and renewal alerts all in one place.

Approved
0
Pending
0
Denied
0
Expiring Soon (30 days)
0
Patient Drug Insurance Submitted Expiration Status PA # Actions
📋
No PAs tracked yet
Click "Add New PA" above to start tracking your first prior authorization
💡 Tip: PAs expiring within 30 days are highlighted in orange. Renew early — most insurers need 2–3 weeks for renewal processing. Data is saved in your browser and persists between sessions.